Profusa, INC. (NVACW) — SEC Filings

Overview

Profusa, INC. (NVACW) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 30, 2025: Profusa, Inc. entered into a Material Definitive Agreement on December 29, 2025. The filing also includes financial statements and exhibits related to this agreement. Profusa, Inc. is incorporated in Delaware and its principal executive offices are located in Berkeley, CA.

Sentiment Summary

Across 50 filings, the sentiment breakdown is: 14 bearish, 34 neutral, 2 mixed. The dominant filing sentiment for Profusa, INC. is neutral.

Filing Type Overview

Profusa, INC. (NVACW) has filed 29 8-K, 6 10-Q, 3 S-1, 1 DEFA14A, 4 DEF 14A, 3 S-1/A, 2 8-K/A, 1 10-K, 1 SC 13G with the SEC between Mar 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (50)

• Profusa, Inc. Files 8-K for Material Agreement — 8-K · Dec 30, 2025 Risk: medium
  Profusa, Inc. entered into a Material Definitive Agreement on December 29, 2025. The filing also includes financial statements and exhibits related to this agre
• Profusa, Inc. Files 8-K: Material Agreement & Financials — 8-K · Dec 23, 2025 Risk: medium
  Profusa, Inc. filed an 8-K on December 23, 2025, reporting a material definitive agreement and financial statements. The company, formerly NorthView Acquisition
• Profusa, Inc. Files 8-K: Other Events & Exhibits — 8-K · Nov 20, 2025 Risk: low
  Profusa, Inc. filed an 8-K on November 20, 2025, reporting on events that occurred on November 19, 2025. The filing pertains to "Other Events" and "Financial St
• Profusa's Losses Mount Post-Merger Amid Nasdaq Delisting Threat — 10-Q · Nov 19, 2025 Risk: high
  Profusa, Inc. (NVACW) reported a significant net loss of $(27.256) million for the nine months ended September 30, 2025, a substantial increase from $(6.978) mi
• Profusa, Inc. Faces Delisting Concerns — 8-K · Nov 3, 2025 Risk: high
  Profusa, Inc. filed an 8-K on November 3, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The earliest event reported was
• Profusa, Inc. Relocates HQ, Updates Contact Info — 8-K · Oct 30, 2025 Risk: low
  Profusa, Inc. filed an 8-K on October 30, 2025, reporting a change in its principal executive offices to 626 Bancroft Way, Suite A, Berkeley, CA 94710. The comp
• Profusa, Inc. Files 8-K — 8-K · Oct 21, 2025 Risk: low
  Profusa, Inc. filed an 8-K on October 21, 2025, reporting an event on October 20, 2025. The filing is categorized under Regulation FD Disclosure and Financial S
• Profusa Files S-1 for $100M Equity Facility, Bitcoin Purchase Plan — S-1 · Oct 9, 2025 Risk: high
  Profusa, Inc. (formerly NorthView Acquisition Corporation) filed an S-1 on October 9, 2025, primarily for the resale of up to 42,594,048 shares of common stock.
• Profusa, Inc. Files 8-K on Material Agreement — 8-K · Oct 8, 2025 Risk: medium
  Profusa, Inc. filed an 8-K on October 8, 2025, reporting on events that occurred on October 1, 2025. The filing indicates a material definitive agreement was en
• Profusa, Inc. Files Definitive Additional Materials — DEFA14A · Oct 7, 2025 Risk: low
  Profusa, Inc. filed a Definitive Additional Materials (DEFA14A) on October 7, 2025, related to its proxy statement. This filing concerns materials provided to s
• Profusa Seeks Shareholder Nod for Convertible Notes, Doubling Authorized Shares — DEF 14A · Sep 23, 2025 Risk: high
  Profusa, Inc. (NVACW) is holding a special meeting on October 7, 2025, to seek stockholder approval for two critical proposals. The first is to approve the pote
• Profusa Amends Note Terms, Registers 222M Shares for Ascent Resale — S-1/A · Sep 17, 2025 Risk: high
  Profusa, Inc. (formerly NorthView Acquisition Corporation) filed an S-1/A on September 16, 2025, primarily for the resale of up to 222,222,222 shares of common
• Profusa, Inc. Files 8-K on Delisting Concerns — 8-K · Sep 16, 2025 Risk: high
  Profusa, Inc. filed an 8-K on September 16, 2025, reporting a notice of delisting or failure to satisfy continued listing rules. The filing also includes financ
• Profusa, Inc. Files 8-K on Security Holder Votes & Financials — 8-K · Sep 4, 2025 Risk: low
  Profusa, Inc. filed an 8-K on August 29, 2025, reporting on the submission of matters to a vote of security holders and financial statements. The company, forme
• Profusa Finalizes Merger, Secures $22.2M Convertible Note Facility — S-1 · Aug 29, 2025 Risk: high
  Profusa, Inc. (formerly NorthView Acquisition Corporation) completed its business combination on July 11, 2025, becoming a wholly-owned subsidiary. The company
• Profusa, Inc. Enters Material Definitive Agreement — 8-K · Aug 26, 2025 Risk: medium
  Profusa, Inc. announced on August 25, 2025, that it entered into a Material Definitive Agreement. The company, formerly known as NorthView Acquisition Corp unti
• Profusa Secures $100M Equity Facility for Bitcoin Buys Post-Merger — S-1/A · Aug 22, 2025 Risk: high
  Profusa, Inc. (formerly NorthView Acquisition Corporation) completed its business combination on July 11, 2025, becoming a wholly-owned subsidiary of the Compan
• Profusa Secures $100M Equity Line, Eyes Bitcoin for Capital Deployment — S-1/A · Aug 21, 2025 Risk: high
  Profusa, Inc. (formerly NorthView Acquisition Corporation) completed a business combination on July 11, 2025, merging with Profusa, Inc., a California corporati
• Profusa, Inc. Files 8-K — 8-K · Aug 19, 2025 Risk: low
  Profusa, Inc. filed an 8-K on August 19, 2025, reporting on other events and financial statements. The company, formerly NorthView Acquisition Corp, changed its
• Profusa, Inc. Files Definitive Proxy Statement — DEF 14A · Aug 18, 2025 Risk: low
  Profusa, Inc. filed its definitive proxy statement on August 18, 2025, for its annual meeting of stockholders. The filing, designated as DEF 14A, concerns the c
• Profusa, Inc. Files 8-K/A Amendment — 8-K/A · Aug 15, 2025 Risk: low
  Profusa, Inc. filed an amendment (Amendment No. 1) to its Form 8-K on August 15, 2025, related to a material definitive agreement entered into on July 11, 2025.
• Profusa's Net Loss Skyrockets to $9.3M Amidst SPAC Merger Completion — 10-Q · Aug 14, 2025 Risk: high
  Profusa, Inc. (formerly NorthView Acquisition Corp.) reported a significant increase in net loss for the six months ended June 30, 2025, reaching $9,316,786, a
• S-1 Filing — S-1 · Aug 11, 2025
• Profusa, Inc. Files 8-K: Other Events & Financials — 8-K · Aug 7, 2025 Risk: low
  Profusa, Inc. filed an 8-K on August 7, 2025, reporting other events and financial statements. The company, formerly NorthView Acquisition Corp, changed its nam
• Profusa, Inc. Files 8-K for Material Agreement & Equity Sales — 8-K · Jul 28, 2025 Risk: medium
  Profusa, Inc. filed an 8-K on July 28, 2025, reporting a material definitive agreement and unregistered sales of equity securities. The company, formerly NorthV
• Profusa, Inc. Files 8-K Detailing Major Corporate Events — 8-K · Jul 18, 2025 Risk: medium
  Profusa, Inc. filed an 8-K on July 18, 2025, reporting several material events including the entry into a definitive agreement, completion of an acquisition, cr
• NorthView Acquisition Corp. Files 8-K — 8-K · Jul 3, 2025 Risk: low
  NorthView Acquisition Corp. filed an 8-K on July 3, 2025, reporting events as of June 27, 2025. The filing primarily concerns amendments to its articles of inco
• NorthView Posts $1M Loss, Continues SPAC Hunt — 10-Q · Jun 13, 2025 Risk: high
  NorthView Acquisition Corp. reported no revenue for the three months ended March 31, 2025, consistent with its status as a Special Purpose Acquisition Company (
• NorthView Acquisition Corp. Files 8-K — 8-K · Jun 9, 2025 Risk: low
  NorthView Acquisition Corp. filed an 8-K on June 9, 2025, reporting events as of June 5, 2025. The filing details the company's structure, including shares of c
• NorthView Acquisition Corp. Signs Material Definitive Agreement — 8-K · May 15, 2025 Risk: medium
  NorthView Acquisition Corp. (NVAC) entered into a material definitive agreement on May 8, 2025. The filing details the company's structure, including shares of
• NorthView Acquisition Corp. Files 8-K: Accountant Change — 8-K · May 2, 2025 Risk: low
  NorthView Acquisition Corp. filed an 8-K on May 2, 2025, reporting changes in its certifying accountant as of April 30, 2025. The filing also includes financial
• NorthView Acquisition Corp. Files 2024 Annual Report — 10-K · Mar 31, 2025 Risk: low
  NorthView Acquisition Corp. filed its 10-K for the fiscal year ended December 31, 2024. The company, incorporated in Delaware with its principal executive offic
• NorthView Acquisition Corp. Files 8-K on Corporate Changes — 8-K · Mar 26, 2025 Risk: low
  NorthView Acquisition Corp. filed an 8-K on March 26, 2025, reporting on events as of March 21, 2025. The filing primarily concerns amendments to its Articles o
• NorthView Acquisition Corp. Files 8-K — 8-K · Mar 18, 2025 Risk: low
  NorthView Acquisition Corp. filed an 8-K on March 18, 2025, reporting on other events and financial statements. The filing details the company's structure, incl
• NorthView Acquisition Corp. Files Definitive Proxy Statement — DEF 14A · Mar 7, 2025 Risk: low
  NorthView Acquisition Corp. is filing a Definitive Proxy Statement (DEF 14A) on March 7, 2025, concerning a special meeting. The filing details the company's co
• NorthView Acquisition Corp. Files 8-K on Agreements and Securities — 8-K · Feb 19, 2025 Risk: medium
  NorthView Acquisition Corp. entered into a Material Definitive Agreement on February 11, 2025, related to the creation of a direct financial obligation. The com
• NorthView Acquisition Corp. Faces Delisting Concerns — 8-K · Dec 26, 2024 Risk: high
  NorthView Acquisition Corp. (NVAC) filed an 8-K on December 20, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The filing
• NorthView Acquisition Corp. Files Q3 2024 10-Q — 10-Q · Dec 17, 2024 Risk: low
  NorthView Acquisition Corp. filed its 10-Q for the quarterly period ended September 30, 2024. The company, incorporated in Delaware, is involved in the Surgical
• NorthView Acquisition Corp. Faces Delisting Notice — 8-K · Dec 12, 2024 Risk: high
  NorthView Acquisition Corp. (NVAC) filed an 8-K on December 12, 2024, reporting a notice of delisting or failure to satisfy continued listing rules as of Decemb
• NorthView Acquisition Corp. Files Q2 2024 10-Q Report — 10-Q · Nov 15, 2024 Risk: low
  NorthView Acquisition Corp. filed its quarterly report on Form 10-Q for the period ended June 30, 2024. The company, incorporated in Delaware, is involved in th
• NorthView Acquisition Corp. Faces Delisting Concerns — 8-K · Oct 21, 2024 Risk: high
  NorthView Acquisition Corp. (NVAC) filed an 8-K on October 21, 2024, reporting a notice of delisting or failure to satisfy continued listing rules as of October
• NorthView Acquisition Corp. Files Q1 2024 10-Q — 10-Q · Oct 9, 2024 Risk: low
  NorthView Acquisition Corp. filed its 10-Q for the quarterly period ended March 31, 2024. The company, incorporated in Delaware, is involved in the Surgical & M
• NorthView Acquisition Corp. Files 8-K/A Amendment — 8-K/A · Oct 4, 2024 Risk: medium
  NorthView Acquisition Corp. filed an amendment (8-K/A) on October 4, 2024, to its Form 8-K originally reported on September 12, 2024. This amendment pertains to
• NorthView Acquisition Corp. Reports Director, Officer, and Bylaw Changes — 8-K · Sep 23, 2024 Risk: medium
  NorthView Acquisition Corp. filed an 8-K on September 23, 2024, reporting on several key events that occurred on September 19, 2024. These include the departure
• NorthView Acquisition Corp. Faces Nasdaq Delisting Notice — 8-K · Sep 13, 2024 Risk: high
  NorthView Acquisition Corp. (NVAC) announced on September 12, 2024, that it received a notice from the Nasdaq Stock Market indicating a failure to meet continue
• NorthView Acquisition Corp Files Definitive Proxy Statement — DEF 14A · Sep 11, 2024 Risk: low
  NorthView Acquisition Corp. filed a definitive proxy statement (DEF 14A) on September 11, 2024, for its fiscal year ending December 31, 2024. The company, incor
• NorthView Acquisition Corp. Faces Nasdaq Delisting Notice — 8-K · Jun 7, 2024 Risk: high
  NorthView Acquisition Corp. (NVAC) announced on June 3, 2024, that it received a notice from the Nasdaq Stock Market indicating a failure to meet continued list
• SC 13G Filing — SC 13G · Mar 27, 2024
• NorthView Acquisition Corp. Sets Shareholder Vote for AONIA Merger — 8-K · Mar 26, 2024 Risk: medium
  NorthView Acquisition Corp. announced on March 21, 2024, that it will hold a special meeting of its stockholders on April 22, 2024, to vote on a proposed busine
• NorthView Acquisition Corp. Files 8-K — 8-K · Mar 14, 2024 Risk: medium
  NorthView Acquisition Corp. (NVAC) entered into a Material Definitive Agreement on March 4, 2024. The filing details the company's structure, including shares o

Risk Profile

Risk Assessment: Of NVACW's 48 recent filings, 16 were flagged as high-risk, 12 as medium-risk, and 20 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Profusa, INC.'s most recent 10-Q filing (Nov 19, 2025):

• Revenue: Not Disclosed
• Net Income: $(27.256)M
• EPS: Not Disclosed
• Debt-to-Equity: Not Disclosed
• Cash Position: $3.009M
• Operating Margin: Not Disclosed
• Total Assets: $4.250M
• Total Debt: $38.210M

Key Executives

• Ben C. Hwang
• Ben C. Hwang, Ph.D.
• Ralph V. De Martino, Esq.
• Marc Rivera, Esq.

Industry Context

The medical device industry, particularly in areas like oxygen monitoring, is highly competitive and innovation-driven. Companies like Profusa are navigating a landscape that requires significant R&D investment, regulatory approvals (like FDA and CE marking), and effective commercialization strategies to gain market share. The trend towards connected health and remote patient monitoring presents opportunities, but also necessitates robust data security and integration capabilities.

Top Tags

material-agreement (7) · delisting (7) · Biotechnology (6) · Medical Devices (5) · listing-standards (5) · Dilution Risk (5) · filing-update (4) · proxy-statement (4) · corporate-governance (4) · 10-Q (4)

Key Numbers

• Net Loss: $(27.256)M — Increased from $(6.978)M in 2024 for the nine months ended September 30.
• Working Capital Deficit: $(19.3)M — As of September 30, 2025, indicating liquidity challenges.
• Total Operating Expenses: $24.136M — For the nine months ended September 30, 2025, a significant increase from $3.518M in 2024.
• Cash: $3.009M — As of September 30, 2025, up from $191K at December 31, 2024, due to financing.
• Committed Equity Facility: $100M — Available from Ascent, providing potential future liquidity.
• Nasdaq MVLS Requirement: $50M — Company failed to meet this, leading to a delisting notice.
• Common Shares Outstanding: 65,680,958 — As of November 18, 2025, significantly increased from prior periods.
• Bitcoin Coins: 8.53 — Purchased for $1.0 million as part of treasury strategy.
• Shares of Common Stock: 42,594,048 — Total shares registered for resale by Selling Stockholders
• Maximum Aggregate Purchase Price: $100,000,000 — Total value of common stock Profusa may sell to Ascent
• Purchase Price Percentage: 97% — Percentage of lowest VWAP for shares sold to Ascent
• Last Sale Price: $0.33 — Profusa's common stock price on Nasdaq Global Market as of October 7, 2025
• Business Combination Date: July 11, 2025 — Date Profusa completed its merger with NorthView Acquisition Corporation
• Purchase Agreement Date: July 28, 2025 — Date Profusa entered into the Purchase Agreement with Ascent
• Term of Purchase Agreement: 36 months — Period over which Profusa can sell shares to Ascent

Related Companies

PFSA · NVAC · NVACR · AONIA

Frequently Asked Questions